Pressure BioSciences, Inc. (PBIO) ProteoSolve-LRS Technology Plays Significant Role in Identyfing Potential Biomarkers in Cancer
Pressure BioSciences announced this morning that the scientists at New York University reported that the Company's award winning technology, the ProteoSolve-LRS, had a large part in identifying potential biomarkers in breast and colon cancer tissue. The results were presented at the LC-MS Course and Symposium, Robinson College, Cambridge, England by Dr. Paul Pevsner of the NYU School of Medicine Department of Pharmacology. The ProteoSolve-LRS was recently released by the company to provide a solution for the detergent-free removal of proteins from lipid-rich tissues as well as other tissues. The study of proteins could lead to a better understanding of many…